RecruitingPhase 2NCT06226883A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseSponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Fayetteville, NC · High Point, NC · Raleigh, NC · +22 more sites
RecruitingPhase 3NCT07184931An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseSponsor: SanofiChapel Hill, NC · Charlotte, NC · Durham, NC · +122 more sites
RecruitingPhase 2NCT07113522A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel DiseaseSponsor: Mirador Therapeutics, Inc.High Point, NC · Raleigh, NC · +44 more sites